Back
Theriva Biologics, Inc. 10K Form
Sell
14
TOVX
Theriva Biologics, Inc.
Last Price:
$0.24
Seasonality Move:
13.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TOVX News And Ratings
See the #1 stock for the next 7 days that we like better than TOVX
TOVX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-4.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.65 |
| Price / Book: | 1 |
Profitability
| EPS (TTM): | -5.53660 |
|---|---|
| Net Income (TTM): | $-26.2M |
| Gross Margin: | $-137K |
| Return on Equity: | -171.04% |
| Return on Assets: | -73.29% |
Theriva Biologics, Inc. Earnings Forecast
Key Theriva Biologics, Inc. Financial Ratios
-
Per Share Earnings over the last 30 years have been positive in 18 years.
Theriva Biologics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TOVX |
| Website: | therivabio.com |
Debt
| Debt-to-Equity Ratio: | 0.41 |
|---|---|
| Current Ratio: | 0.9 |
| Quick Ratio: | 0.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TOVX Technical Analysis vs Fundamental Analysis
Sell
14
Theriva Biologics, Inc. (TOVX)
is a Sell
Is Theriva Biologics, Inc. a Buy or a Sell?
-
Theriva Biologics, Inc. stock is rated a SellThe current Theriva Biologics, Inc. [TOVX] share price is $0.20. The Score for TOVX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.